Hoosier State Today

Today, the National Security Commission on Emerging Biotechnology (NSCEB) presented its significant report and action plan to Congress. U.S. Senator Todd Young, who chairs the Commission, highlighted the urgent need for Congressional action to ensure the United States remains a leader in biotechnology, a field vital for national security and economic influence.

The report underscores concerns about U.S. competitiveness, noting a potential lag behind China in biotechnology. “The United States is locked in a competition with China that will define the coming century. Biotechnology is the next phase in that competition," stated Senator Young. The Commission points out that biotechnology's role extends beyond scientific realms and could enhance supply chain security and manufacturing.

Biotechnology's rapid advances and its intersection with artificial intelligence are transforming sectors like agriculture and defense, according to NSCEB's findings. The Commission warns of the national security risks posed by relying on China for vital supply chain components and stresses the need for the U.S. to drive biotechnology standards. “Technology is not inherently good or bad, but who uses it matters," added NSCEB Vice Chair Dr. Michelle Rozo.

The report calls for strategic federal action to stimulate private investment in biotechnology, suggesting regulatory reforms to encourage innovation. NSCEB Commissioner Senator Alex Padilla noted biotechnology's potential for job creation across various industries. NSCEB Commissioner Representative Stephanie Bice emphasized the importance of U.S. leadership in biotechnology to surpass China in the 21st century.

The Commission proposes six pillars for action and 49 recommendations aimed at maintaining U.S. leadership in biotechnology. “We must embolden the best and brightest in biotechnology to innovate boldly," said NSCEB Commissioner Representative Ro Khanna. Full details of the report can be accessed at biotech.senate.gov.

Background on NSCEB describes it as a legislative advisory body focused on advancing biotechnology for U.S. national security. The Commission comprises members from Congress and experts from various sectors.